The board of directors of PD-Rx Pharmaceuticals Inc (OTC:PDRX) Thursday declared its onetime dividend of USD2.20 per share of its stock.
Shareholders of record at the close of business as of 30 November 2018 will receive the dividend on 12 December 2018.
According to the company, it offers pharmaceutical and management strategies to the healthcare industry,with focus on new products, solid business partners and the specialised segment of the pharmaceutical industry.
As a licensed FDA manufacturer and packager, the company offers a full spectrum of medications, specialised services, proprietary products and prepackaged medications that are viewed by patient, insurance payers and healthcare providers as a progressive and responsive practice.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development